APA (7th ed.) Citation

Rosenberg, J. E., & Jäger, D. (2016). Nivolumab monotherapy in metastatic urothelial cancer (mUC): Updated efficacy by subgroups and safety results from the CheckMate 032 study. Annals of oncology, 27, . https://doi.org/10.1093/annonc/mdw373.12

Chicago Style (17th ed.) Citation

Rosenberg, Jonathan E., and Dirk Jäger. "Nivolumab Monotherapy in Metastatic Urothelial Cancer (mUC): Updated Efficacy by Subgroups and Safety Results from the CheckMate 032 Study." Annals of Oncology 27 (2016). https://doi.org/10.1093/annonc/mdw373.12.

MLA (9th ed.) Citation

Rosenberg, Jonathan E., and Dirk Jäger. "Nivolumab Monotherapy in Metastatic Urothelial Cancer (mUC): Updated Efficacy by Subgroups and Safety Results from the CheckMate 032 Study." Annals of Oncology, vol. 27, 2016, https://doi.org/10.1093/annonc/mdw373.12.